Opinion|Videos|December 29, 2025
Available Treatments and Results in Steroid Refractory/Dependent cGVHD
Author(s)Leyla O. Shune, MD
Leyla O. Shune, MD, describes the available treatment options for patients with chronic graft-versus-host disease who are steroid refractory/dependent. She also discusses treatment approaches and results with these agents in clinical trials and in real-world settings.
Advertisement
Episodes in this series
Leyla O. Shune, MD, describes the available treatment options for patients with chronic graft-versus-host disease who are steroid refractory/dependent. She also discusses treatment approaches and results with these agents in clinical trials and in real-world settings.
Advertisement
Related to this article
Financial strain often eases after allogeneic bone marrow transplant, but persistent hardship worsens quality of life, highlighting the need for ongoing support.
Advertisement
Advertisement
Trending on Targeted Onc
1
HT-001 Trial Ended Early, Phase 3 Planned for EGFR Inhibitor Rash Management
2
Zanubrutinib Plus Rituximab Receives FDA Priority Review in Frontline MCL
3
A New Era in Sarcoma Treatment? Dr Banks on the Potential of TIL Therapy
4
Enfortumab Vedotin/Pembrolizumab Cost Effective in Bladder Cancer
5